Biological characterization of non-steroidal progestins from botanicals used for women's health

Steroids

Volumn 77, Issue 7, 2012, Pages 765-773

  Toh, M F ^a   Sohn, J ^a   Chen, S N ^a   Yao, P ^a   Bolton, J L ^a   Burdette, J E ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Apigenin; Flavonoid; Kaempferol; Naringenin; Progesterone receptor; Red clover

Indexed keywords

APIGENIN; GESTAGEN; KAEMPFEROL; NARINGENIN; PROGESTERONE RECEPTOR; RED CLOVER EXTRACT; HORMONE ANTAGONIST; MIFEPRISTONE; PLANT EXTRACT;

ACTAEA RACEMOSA; ANGELICA SINENSIS; ARTICLE; BINDING ASSAY; BIOLOGICAL ACTIVITY; BREAST CANCER CELL LINE; BREAST EPITHELIUM; CONTROLLED STUDY; CORNUS; CORNUS OFFICINALIS; DRUG CYTOTOXICITY; DRUG ISOLATION; DRUG POTENCY; DRUG RECEPTOR BINDING; ENDOMETRIUM CELL; EPITHELIUM CELL; GENE; GENE ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMULUS LUPULUS; LUCIFERASE ASSAY; MEDICINAL PLANT; MOLECULAR LIBRARY; P4 INDUCIBLE GENE; POLARIZATION; PUERARIA LOBATA; RED CLOVER; SIGNAL TRANSDUCTION; STROMA CELL; VALERIANA OFFICINALIS; VITEX AGNUS CASTUS; WOMEN'S HEALTH; FEMALE; METABOLISM; POLYMERASE CHAIN REACTION; TUMOR CELL LINE; WESTERN BLOTTING;

TRIFOLIUM PRATENSE;

BLOTTING, WESTERN; CELL LINE, TUMOR; FEMALE; HORMONE ANTAGONISTS; HUMANS; MIFEPRISTONE; PLANT EXTRACTS; POLYMERASE CHAIN REACTION; PROGESTINS; RECEPTORS, PROGESTERONE; WOMEN'S HEALTH;

EID: 84864548870     PISSN: 0039128X     EISSN: 18785867     Source Type: Journal    
DOI: 10.1016/j.steroids.2012.03.013     Document Type: Article

References (47)

1. Scarpin KM, Graham JD, Mote PA, Clarke CL. Progesterone action in human tissues: regulation by progesterone receptor (PR) isoform expression, nuclear positioning and coregulator expression. Nucl Recept Signal 2009;7:e009.
2. Gronemeyer H, Meyer ME, Bocquel MT, Kastner P, Turcotte B, Chambon P. Progestin receptors: isoforms and antihormone action. J Steroid Biochem Mol Biol 1991;40:271-8.
3. Aupperlee MD, Haslam SZ. Differential hormonal regulation and function of progesterone receptor isoforms in normal adult mouse mammary gland. Endocrinology 2007;148:2290-300. (Pubitemid 46997067)
4. Mulac-Jericevic B, Lydon JP, DeMayo FJ, Conneely OM. Defective mammary gland morphogenesis in mice lacking the progesterone receptor B isoform. Proc Natl Acad Sci U S A 2003;100:9744-9. (Pubitemid 37087012)
5. Peluso JJ, Romak J, Liu X. Progesterone receptor membrane component-1 (PGRMC1) is the mediator of progesterone's antiapoptotic action in spontaneously immortalized granulosa cells as revealed by PGRMC1 small interfering ribonucleic acid treatment and functional analysis of PGRMC1 mutations. Endocrinology 2008;149:534-43. (Pubitemid 351159360)
6. Vierikko P, Kauppila A, Ronnberg L, Vihko R. Steroidal regulation of endometriosis tissue: lack of induction of 17 beta-hydroxysteroid dehydrogenase activity by progesterone, medroxyprogesterone acetate, or danazol. Fertil Steril 1985;43:218-24. (Pubitemid 15127345)
7. Soper JT, McCarty Jr KS, Creasman WT, Clarke-Pearson DL, McCarty Sr KS. Induction of cytoplasmic progesterone receptor in human endometrial carcinoma transplanted into nude mice. Am J Obstet Gynecol 1984;150:437-9. (Pubitemid 14014050)
8. Kuhl H, Stevenson J. The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits - an attempt to interpret the Women's Health Initiative results. Gynecol Endocrinol 2006;22:303-17. (Pubitemid 43941407)
9. Mosher WD, Jones J. Use of contraception in the United States: 1982-2008. Vital Health Stat 2010;23:1-44.
10. Milsom I. Odlind V [Oral contraceptives give long-lasting protection against ovarian cancer. Use of oral contraceptives can explain reduced incidence of ovarian cancer in Sweden]. Lakartidningen 2008;105:715-6.
11. Chwalisz K, Perez MC, Demanno D, Winkel C, Schubert G, Elger W. Selective progesterone receptor modulator development and use in the treatment of leiomyomata and endometriosis. Endocr Rev 2005;26:423-38. (Pubitemid 40686652)
12. Liu J, Burdette JE, Xu H, Gu C, van Breemen RB, Bhat KP, et al. Evaluation of estrogenic activity of plant extracts for the potential treatment of menopausal symptoms. J Agric Food Chem 2001;49:2472-9. (Pubitemid 32843277)
13. Burdette JE, Liu J, Lantvit D, Lim E, Booth N, Bhat KP, et al. Trifolium pratense (red clover) exhibits estrogenic effects in vivo in ovariectomized Sprague-Dawley rats. J Nutr 2002;132:27-30. (Pubitemid 34042450)
14. Overk CR, Guo J, Chadwick LR, Lantvit DD, Minassi A, Appendino G, et al. In vivo estrogenic comparisons of Trifolium pratense (red clover) Humulus lupulus (hops), and the pure compounds isoxanthohumol and 8-prenylnaringenin. Chem Biol Interact 2008;176:30-9.
15. Chadwick LR, Nikolic D, Burdette JE, Overk CR, Bolton JL, van Breemen RB, et al. Estrogens and congeners from spent hops (Humulus lupulus). J Nat Prod 2004;67:2024-32. (Pubitemid 40092549)
16. Krikun G, Mor G, Alvero A, Guller S, Schatz F, Sapi E, et al. A novel immortalized human endometrial stromal cell line with normal progestational response. Endocrinology 2004;145:2291-6. (Pubitemid 38535058)
17. Sukerkar PA, Macrenaris KW, Townsend TR, Ahmed RA, Burdette JE, Meade TJ. Synthesis and biological evaluation of water-soluble progesterone-conjugated probes for magnetic resonance imaging of hormone related cancers. Bioconjug Chem 2011;22:2304-16.
18. Nardulli AM, Katzenellenbogen BS. Progesterone receptor regulation in T47D human breast cancer cells: analysis by density labeling of progesterone receptor synthesis and degradation and their modulation by progestin. Endocrinology 1988;122:1532-40. (Pubitemid 18091988)
19. Booth NL, Overk CR, Yao P, Burdette JE, Nikolic D, Chen SN, et al. The chemical and biologic profile of a red clover (Trifolium pratense L.) phase II clinical extract. J Altern Complement Med 2006;12:133-9.
20. Overk CR, Yao P, Chadwick LR, Nikolic D, Sun Y, Cuendet MA, et al. Comparison of the in vitro estrogenic activities of compounds from hops (Humulus lupulus) and red clover (Trifolium pratense). J Agric Food Chem 2005;53:6246-53. (Pubitemid 41169368)
21. Sirait M, Rimpler H, Haensel R. Flavonoids from Vitex agnus castus L. Experientia. 1962;18:72.
22. Afhuppe W, Sommer A, Muller J, Schwede W, Fuhrmann U, Moller C. Global gene expression profiling of progesterone receptor modulators in T47D cells provides a new classification system. J Steroid Biochem Mol Biol 2009;113:105-15.
23. Mulac-Jericevic B, Conneely OM. Reproductive tissue-selective actions of progesterone receptors. Ernst Schering Res Found Workshop 2005:19-37.
24. Simon L, Spiewak KA, Ekman GC, Kim J, Lydon JP, Bagchi MK, et al. Stromal progesterone receptors mediate induction of Indian Hedgehog (IHH) in uterine epithelium and its downstream targets in uterine stroma. Endocrinology 2009;150:3871-6.
25. Buzzio OL, Lu Z, Miller CD, Unterman TG, Kim JJ. FOXO1A differentially regulates genes of decidualization. Endocrinology 2006;147:3870-6. (Pubitemid 44079392)
26. Abdel-Hafiz H, Takimoto GS, Tung L, Horwitz KB. The inhibitory function in human progesterone receptor N termini binds SUMO-1 protein to regulate autoinhibition and transrepression. J Biol Chem 2002;277:33950-6.
27. Bulun SE, Cheng YH, Yin P, Imir G, Utsunomiya H, Attar E, et al. Progesterone resistance in endometriosis: link to failure to metabolize estradiol. Mol Cell Endocrinol 2006;248:94-103.
28. Mafuvadze B, Benakanakere I, Lopez Perez FR, Besch-Williford C, Ellersieck MR, Hyder SM. Apigenin prevents development of medroxyprogesterone acetate-accelerated 7,12-dimethylbenz(a)anthracene-induced mammary tumors in Sprague-Dawley rats. Cancer Prev Res (Phila) 2011;4:1316-24.
29. Geller SE, Shulman LP, van Breemen RB, Banuvar S, Zhou Y, Epstein G, et al. Safety and efficacy of black cohosh and red clover for the management of vasomotor symptoms: a randomized controlled trial. Menopause 2009;16:1156-66.
30. Zhao D, Lebovic DI, Taylor RN. Long-term progestin treatment inhibits RANTES (regulated on activation, normal T cell expressed and secreted) gene expression in human endometrial stromal cells. J Clin Endocrinol Metab 2002;87:2514-9. (Pubitemid 34655307)
31. Wang Y, Hanifi-Moghaddam P, Hanekamp EE, Kloosterboer HJ, Franken P, Veldscholte J, et al. Progesterone inhibition of Wnt/beta-catenin signaling in normal endometrium and endometrial cancer. Clin Cancer Res 2009;15:5784-93.
32. Brar AK, Frank GR, Kessler CA, Cedars MI, Handwerger S. Progesterone-dependent decidualization of the human endometrium is mediated by cAMP. Endocrine 1997;6:301-7. (Pubitemid 27431402)
33. Gellersen B, Brosens J. Cyclic AMP and progesterone receptor cross-talk in human endometrium: a decidualizing affair. J Endocrinol 2003;178:357-72. (Pubitemid 37220163)
34. Zand RS, Jenkins DJ, Diamandis EP. Steroid hormone activity of flavonoids and related compounds. Breast Cancer Res Treat 2000;62:35-49. (Pubitemid 30609562)
35. Stroheker T, Pinnert MF, Picard K, Chagnon MC, Canivenc-Lavier MC. Estrogenic effects of apigenin, kaempferol and bisphenol A in immature Wistar female rats and in MCF-7 cells. IARC Sci Publ 2002;156:413-4.
36. Mafuvadze B, Benakanakere I, Hyder SM. Apigenin blocks induction of vascular endothelial growth factor mRNA and protein in progestin-treated human breast cancer cells. Menopause 2010;17:1055-63.
37. Hamalainen M, Nieminen R, Vuorela P, Heinonen M, Moilanen E. Antiinflammatory effects of flavonoids: genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-kappaB activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-kappaB activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages. Mediators Inflamm 2007;2007:45673.
38. Kim SK, Kim HJ, Choi SE, Park KH, Choi HK, Lee MW. Anti-oxidative and inhibitory activities on nitric oxide (NO) and prostaglandin E2 (COX-2) production of flavonoids from seeds of Prunus tomentosa Thunberg. Arch Pharm Res 2008;31:424-8.
39. van der Burg B, van der Saag PT. Nuclear factor-kappa-B/steroid hormone receptor interactions as a functional basis of anti-inflammatory action of steroids in reproductive organs. Mol Hum Reprod 1996;2:433-8.
40. Loudon JA, Elliott CL, Hills F, Bennett PR. Progesterone represses interleukin-8 and cyclo-oxygenase-2 in human lower segment fibroblast cells and amnion epithelial cells. Biol Reprod 2003;69:331-7. (Pubitemid 36806839)
41. Luo H, Jiang BH, King SM, Chen YC. Inhibition of cell growth and VEGF expression in ovarian cancer cells by flavonoids. Nutr Cancer 2008;60:800-9.
42. McCann SE, Freudenheim JL, Marshall JR, Graham S. Risk of human ovarian cancer is related to dietary intake of selected nutrients, phytochemicals and food groups. J Nutr 2003;133:1937-42. (Pubitemid 36666538)
43. Gates MA, Tworoger SS, Hecht JL, De Vivo I, Rosner B, Hankinson SE. A prospective study of dietary flavonoid intake and incidence of epithelial ovarian cancer. Int J Cancer 2007;121:2225-32. (Pubitemid 47585602)
44. Terry KL, De Vivo I, Titus-Ernstoff L, Sluss PM, Cramer DW. Genetic variation in the progesterone receptor gene and ovarian cancer risk. Am J Epidemiol 2005;161:442-51. (Pubitemid 40315615)
45. Gunther S, Patterson RE, Kristal AR, Stratton KL, White E. Demographic and health-related correlates of herbal and specialty supplement use. J Am Diet Assoc 2004;104:27-34. (Pubitemid 38058295)
46. Kelly JP, Kaufman DW, Kelley K, Rosenberg L, Anderson TE, Mitchell AA. Recent trends in use of herbal and other natural products. Arch Intern Med 2005;165:281-6. (Pubitemid 40216279)
47. de Voogt HJ, Smith PH, Pavone-Macaluso M, de Pauw M, Suciu S. Cardiovascular side effects of diethylstilbestrol, cyproterone acetate, medroxyprogesterone acetate and estramustine phosphate used for the treatment of advanced prostatic cancer: results from European Organization for Research on Treatment of Cancer trials 30761 and 30762. J Urol 1986;135:303-7. (Pubitemid 16131365)